Harvard Bioscience, Inc. (HBI.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 08:05AM CEST
| Previous Close | 3.4400 |
| Open | 3.2200 |
| Bid | 3.2400 x 240000 |
| Ask | 3.3000 x 240000 |
| Day's Range | 3.2200 - 3.2200 |
| 52 Week Range | 3.2200 - 5.6500 |
| Volume | |
| Avg. Volume | 14 |
| Market Cap | 139.817M |
| Beta (5Y Monthly) | 1.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1900 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.00 |
Insider MonkeyHarvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript May 7, 2024 Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.10815 EPS, expectations were $0.02. Harvard Bioscience, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
- GuruFocus.com
Harvard Bioscience Inc (HBIO) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Despite a revenue dip, HBIO maintains robust margins and advances strategic initiatives to bolster future growth.
GuruFocus.comHarvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
First Quarter Reveals Revenue Decline and Net Loss, Despite Strong Gross Margin
© 2024 Yahoo. All rights reserved.